VIRIOM

viriom-logo

Viriom Inc. is a development and commercial stage biotech company developing novel and affordable medicines against life threatening infections such as HIV and HBV. The company has an exclusive worldwide license to its phase 3 and commercial stage lead compounds (Elpida/elsulfavirine and VM1500A) from Hoffmann-La Roche and has developed proprietary drug candidates VM2500, VM3500 LAI formulations and combinations with cell, vaccine and antibody drugs for treatment, prophylaxis and cure of HIV. Viriom makes a breakthrough in treating, preventing and curing HIV and chronic HBV infections worldwide.

#SimilarOrganizations #People #Financial #Website #More

VIRIOM

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2009-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.viriom.com

Total Employee:
251+

Status:
Active

Contact:
+1-858-7944860

Email Addresses:
[email protected]

Total Funding:
35.41 M USD

Technology used in webpage:
Squarespace Hosted


Similar Organizations

acceleron-pharma-logo

Acceleron Pharma

Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

apic-bio-logo

Apic Bio

Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

aztherapies-logo

AZTherapies

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

enbiotix-logo

EnBiotix

EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.


Current Advisors List

klaus-klumpp_image

Klaus Klumpp Virology @ Viriom
Advisor
2009-09-01

janet-hammond_image

Janet Hammond Advisory Board Member @ Viriom
Advisor

alexey-mazus_image

Alexey Mazus Advisor to the Board @ Viriom
Advisor

milos-petrovich_image

Milos Petrovich Adviser to the Board @ Viriom
Board_member

alexey-mazus_image

Alexey Mazus Adviser to Board @ Viriom
Board_member

gerald-j-yakatan_image

Gerald J. Yakatan Advisory Board Member @ Viriom
Advisor
2016-11-01

Current Employees Featured

irina-tyrnova_image

Irina Tyrnova
Irina Tyrnova General Manager @ Viriom
General Manager

not_available_image

MiRa Hygne
MiRa Hygne Head of Clinical Affairs @ Viriom
Head of Clinical Affairs
2017-11-05

boris-rogovoy_image

Boris Rogovoy
Boris Rogovoy Senior Director of Discovery Programs @ Viriom
Senior Director of Discovery Programs
2021-01-01

iain-dukes_image

Iain Dukes
Iain Dukes CEO @ Viriom
CEO
2020-02-01

gus-lawlor_image

Gus Lawlor
Gus Lawlor Director @ Viriom
Director

ronald-demuth_image

Ronald Demuth
Ronald Demuth CFO @ Viriom
CFO
2009-07-01

not_available_image

Robert Murphy
Robert Murphy CMO @ Viriom
CMO
2012-09-12

Investors List

pharmstandard_image

Pharmstandard

Pharmstandard investment in Convertible Note - Viriom

torrey-pines-investment_image

Torrey Pines Investment

Torrey Pines Investment investment in Convertible Note - Viriom

chemrar-high-tech-center_image

ChemRar Ltd

ChemRar Ltd investment in Convertible Note - Viriom

skolkovo-foundation_image

Skolkovo Foundation

Skolkovo Foundation investment in Convertible Note - Viriom

torrey-pines-investment_image

Torrey Pines Investment

Torrey Pines Investment investment in Convertible Note - Viriom

torrey-pines-investment_image

Torrey Pines Investment

Torrey Pines Investment investment in Convertible Note - Viriom

mit-rf_image

MIT RF

MIT RF investment in Seed Round - Viriom

chemrar-ventures_image

ChemRar Ventures

ChemRar Ventures investment in Seed Round - Viriom

mit-rf_image

MIT RF

MIT RF investment in Non Equity Assistance - Viriom

chemrar-ventures_image

ChemRar Ventures

ChemRar Ventures investment in Seed Round - Viriom

Official Site Inspections

http://www.viriom.com

  • Host name: 198.185.159.145
  • IP address: 198.185.159.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Viriom"

Viriom

Viriom Inc. is advancing a pipeline of effective and affordable treatments for diseases of global interest. With our network of partners, we are building a global drug development platform …See details»

Viriom - Org Chart, Teams, Culture & Jobs - The Org

View Viriom's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

Who We Are — Viriom

Chinese Center for Disease Control and Prevention, National Center for AIDS/STD Control and Prevention. Clinical Virology.See details»

What We Do - Viriom

Viriom's flexible global access strategy allows the company to address multiple disease targets exemplified by our programs in viral hepatitis, HIV, COVID-19, and seasonal or pandemic influenza, along with an increasing emphasis on …See details»

Viriom - Crunchbase Company Profile & Funding

Viriom is a clinical and commercial stage biotech developing drugs for treatment, prevention and cure of HIV and other infections. View contacts for Viriom to access new leads and connect with decision-makers.See details»

Viriom Company Profile 2024: Valuation, Funding

Developer of a biotechnology platform intended to focus on pharmaceuticals for treating certain viruses.See details»

Viriom - Products, Competitors, Financials, Employees, …

Viriom Inc. is a biotechnology company developing treatments for infectious and malignant diseases, particularly blood-borne and respiratory viral diseases, as well as solid tumors.See details»

Viriom - Overview, News & Similar companies | ZoomInfo.com

Nov 20, 2023 · Viriom is developing and commerciali zing the most innovative and affordable solutions to radically expand global access to the best antiviral treatments. Viriom's broad, …See details»

Viriom Company Profile - Office Locations, Competitors, Revenue …

Viriom is a biotech company developing therapies and prevention treatments against HIV and hepatitis B virus. Its pipeline includes Elpida, a non-nucleoside reverse transcriptase inhibitor, …See details»

Viriom announces NIH/NIAID and Division of AIDS Collaboration …

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Viriom Inc., a clinical stage antiviral company focused on HIV and viral hepatitis (San Diego, CA), is developing long-acting versions of its …See details»

Respiratory Viral Diseases — Viriom

Viriom supports the development of antiviral drugs for respiratory viruses, RNA polymerase and protease inhibitors for COVID19. Viriom has successfully launched the first Favipiravir-based drug in the world approved for the …See details»

Viriom's Single Pill Influenza Treatment Completes Critical Phase I ...

Nov 20, 2023 · With a robust network of partners, Viriom is building a global drug development platform targeting infectious and malignant diseases. The company focuses on blood-borne …See details»

Viriom partners with government org to create Zika treatments

Jan 6, 2017 · The develops antiviral drugs developer is collaborating with the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD) to help create …See details»

Pipeline - Viriom

Viral diseases comprise global threats to human health and Viriom responds by delivering safe, effective, easy to use and affordable treatments. Our advanced drug development platform …See details»

Viriom outlines plans for upcoming infectious disease trials

Dec 5, 2023 · Viriom plans to extend a Phase I trial investigating its influenza pill AV5124, according to chief science officer Dr David Pauza. The US-based company announced the …See details»

ChemDiv Helps Advance Viriom's Influenza Treatment to …

Dec 19, 2023 · Together, Viriom and ChemDiv showcase AV5124's potent suppression of diverse Influenza A and Influenza B viruses, including drug-resistant variants and highly pathogenic …See details»

Elpida (elsulfavirine) becomes the preferred first line therapy for ...

Feb 2, 2021 · Viriom is developing and commercializing the most innovative and affordable solutions to radically expand global access to the best antiviral treatments. Viriom's broad, …See details»

Viriom Expands Global Licensing Agreement With Roche For

Nov 20, 2013 · Viriom Ltd. is a ChemRar company involved in developing innovative antiviral drugs and combinations, treatment methods, and diagnostics. Viriom conducts scientific …See details»

Viriom Announces Initiation of Phase 2 Study Investigating Efficacy …

San Diego, CA, May 4th, 2020 – Viriom, Inc. (Viriom) announced today the initiation of a Phase 2a study investigating the efficacy of an intramuscular long-acting injectable nanoformulation of …See details»

Viriom Inc - Facebook

Viriom Inc. is a late-stage biotech company developing novel and affordable therapies against life threatening infections such as HIV.See details»

linkstock.net © 2022. All rights reserved